Our exploratory irGEP analysis provided insight into the mechanisms underlying the limited efficacy of ICIs for SCLC, with gene expression signatures related to DNA damage repair and cell proliferation and the expression of SOX11 and MYC being implicated in the lack of immunogenicity. The gene discussed is SOX11; the disease is small cell lung carcinoma.